Vasay, Jessa Mae .
HRN: 22-20-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2026
CEFUROXIME 500MG (TAB)
01/03/2026
01/10/2026
PO
500
Bid
Prom X 20 Hrs
Checking Final Appropriateness
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes